Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology Cannabis

Alcohol more likely to lead to post-sex regret than marijuana or ecstasy

by Eric W. Dolan
February 18, 2018
in Cannabis, Psychopharmacology
(Photo credit: Caesar Sebastian)

(Photo credit: Caesar Sebastian)

Share on TwitterShare on Facebook
Follow PsyPost on Google News

Experiencing regret after sex is more commonly associated with alcohol than marijuana or ecstasy, according to new research published in the journal Psychology & Sexuality.

“A lot of studies suggest that the use of various drugs increases the chances for sexually risky behavior, but few have examined the actual sexual effects of drugs,” said Joseph J. Palamar of New York University, the corresponding author of the study.

“Whether or not someone uses a condom while high is important. However, limiting research to this behavior really ignores the actual sexual responses associated with drug use that may in fact influence one’s decision to have sex with or without a condom.”

The researchers traveled to nightclubs and dance festivals in New York City to survey 679 attendees about their use of alcohol, marijuana, and ecstasy. The participants were 18-25 years old.

They found that alcohol was more likely than marijuana or ecstasy to make people feel more attractive and more attracted to others. Alcohol was also more commonly associated with regret after sex.

“Each drug is associated with its own level of sexual risk,” Palamar told PsyPost. “Alcohol is likely the riskiest as use is not only so common, but also promoted throughout much of society.”

“Even if sex itself isn’t risky while on alcohol, post-sex regret is extremely common as users may hook up with someone they normally wouldn’t have sex with.”

They researchers also found that ecstasy use was associated with greater sexual pleasure and increased body sensitivity.

Alcohol and ecstasy were more commonly linked to increased sexual desire compared to marijuana.

For men, alcohol and ecstasy were more often associated with sexual dysfunction than marijuana. But for women, marijuana and ecstasy were more often associated with sexual dysfunction than alcohol.

“We relied on self-report, which is limited,” Palamar said. “Use of multiple drugs at the same time is also common in this population so it may have been difficult for some users to distinguish between effects of different drugs. Many drugs can also affect memory so recall of sexual experiences could have been impaired.”

The study, “A comparison of self-reported sexual effects of alcohol, marijuana, and ecstasy in a sample of young adult nightlife attendees“, was co-authored by Marybec Griffin-Tomas, Patricia Acosta, Danielle C. Ompad and Charles M. Cleland.

RELATED

Surprising link found between aesthetic chills and political extremism
Anxiety

Single dose of psilocybin provides lasting relief from depression and anxiety in cancer patients

August 27, 2025

Cancer patients with major depression experienced significant and long-lasting improvements after just one psilocybin session, according to new research. Two years later, many showed continued reductions in depression and anxiety, with some requiring no further treatment or medication.

Read moreDetails
Scientists uncover biological pathway that could revolutionize anxiety treatment
MDMA

Psilocybin and MDMA may reset fear-related brain-immune signaling, scientists find

August 25, 2025

Psilocybin and MDMA may do more than alter perception. A study in Nature suggests they also reduce fear by targeting a newly identified immune-brain signaling loop, which becomes hyperactive under chronic stress and contributes to heightened fear responses.

Read moreDetails
Does cannabidiol reduce worry severity or anxiety symptoms? New placebo-controlled study says no
Cannabis

Cannabidiol shows potential to reverse some neuropsychological effects of social stress

August 24, 2025

A non-intoxicating cannabis compound may help protect the brain from the damaging effects of chronic social stress. New research shows cannabidiol reversed stress-related changes in behavior and gene expression in mice exposed to repeated social defeat.

Read moreDetails
Stress-induced “fixated” eating patterns linked to dopamine disruption, study finds
Addiction

Dopamine-boosting drug enhances self-control and reduces drinking in people with alcohol use disorder

August 22, 2025

A new study suggests the dopamine-boosting drug tolcapone may enhance self-control and reduce alcohol intake in people with alcohol use disorder by increasing activity in brain regions linked to inhibitory control, such as the inferior frontal gyrus and prefrontal cortex.

Read moreDetails
New research highlights potential of d-limonene in reducing THC-induced anxiety
Cannabis

Prenatal cannabis exposure linked to blunted brain response and psychotic-like symptoms in youth

August 22, 2025

A new study suggests that children exposed to cannabis in utero show reduced brain activation during reward anticipation—especially in the striatum—and are more likely to report psychotic-like experiences during adolescence. The findings provide evidence of altered neural development tied to prenatal exposure.

Read moreDetails
Research shows diabetes drug could reduce dementia risk. Here’s how the two diseases may be linked
Depression

Antidepressant withdrawal symptoms may be more common and more severe than some studies suggest

August 22, 2025

A new study challenges previous claims that antidepressant withdrawal is rare or mild. Researchers found that more than half of patients report symptoms when discontinuing, suggesting earlier reviews relying on short-term trials may have underestimated the risks.

Read moreDetails
Obesity before pregnancy linked to autism-like behavior in male offspring, study finds
Mental Health

A common painkiller triggered hallucinations mistaken for schizophrenia

August 19, 2025

A recent case report describes how a 67-year-old man was misdiagnosed with schizophrenia after experiencing hallucinations—an adverse reaction linked to his prescribed opioid pain medication. The case highlights the need for more nuanced psychiatric evaluations.

Read moreDetails
Neuroscience research shows psychedelics plus psychotherapy can trigger rapid brain changes
Ayahuasca

Near-death visions and DMT trips share eerie similarities — but key differences set them apart

August 17, 2025

A new study comparing near-death experiences with high-dose DMT trips finds striking similarities — and surprising differences — in what people see and feel. The research sheds light on how the brain might shape extraordinary states of consciousness.

Read moreDetails

STAY CONNECTED

LATEST

A common childhood virus could be silently fueling Alzheimer’s disease in old age

It’s not social media: What’s really fueling Trump shooting conspiracies might surprise you

Autism’s “odd gait”: Autistic movement differences linked to brain development

Scientists achieve “striking” memory improvements by suppressing brain protein

Some neurocognitive deficits from COVID-19 may last for years, study suggests

Single dose of psilocybin provides lasting relief from depression and anxiety in cancer patients

Fascinating new psychology research shows how music shapes imagination

Surprising link found between aesthetic chills and political extremism

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy